Cybersecurity M&A Activity Intensifies as LSEG's AI Platform Attracts Major Financial ClientsGlobal Report·Oct 7, 2026 at 10:13 AMVVV+4.24%GTIM+0.77%
Analyst Reaffirms Buy on OptimizeRx, Citing Strong Second-Half Ramp and Intact 2027 OutlookTip Ranks·Oct 2, 2026 at 08:45 PMOPRX-3.09%
B. Riley Securities maintains Buy rating on OptimizeRx, $11 price targetTradingView·Sep 29, 2026 at 03:45 PMOPRX-3.09%
OptimizeRx integrates with Trade Desk OpenPath to offer authenticated EHR ad inventoryPUBT·Sep 22, 2026 at 12:08 PMTTD+4.53%OPRX-3.09%
OptimizeRx expands Natural Language Audience Builder to add DTC targeting workflowPUBT·Sep 14, 2026 at 12:06 PMOPRX-3.09%
OptimizeRx management participates in Lake Street Capital Best Ideas Growth ConferencePUBT·Sep 8, 2026 at 11:32 AMOPRX-3.09%
OptimizeRx appoints former J&J commercial data science chief Troy Sarich as adviserPUBT·Sep 2, 2026 at 11:31 AMOPRX-3.09%
OptimizeRx (OPRX) Fiscal Q2 2026 Earnings Call: Guidance Reaffirmed as Revenue Falls 30%TradingKey·Aug 14, 2026 at 08:32 AMOPRX-3.09%
OptimizeRx Q2 GAAP net loss narrows to $0.7 million; revenue drops 30% to $20.5 million year over yearPUBT·Aug 12, 2026 at 08:03 PMOPRX-3.09%
